Kintai THERAPEUTICS Logo (WIPO, 10/17/2019)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark Kintai THERAPEUTICS was filed as Figurative mark on 10/17/2019 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Structural works #Circles #Letters presenting a special form of writing #Bridges #Several circles, juxtaposed, tangential or intersecting #Circles with dark surfaces or parts of surfaces #Series of letters in different dimensions
| Trademark form | Figurative mark |
| File reference | 1502261 |
| Countries | 
|
| Base trademark |
No. 88393537,
April 19, 2019
|
| Application date | October 17, 2019 |
| Expiration date | February 22, 2021 |
Trademark owner
20 Acorn Park Drive
Cambridge MA 02140
US
Cambridge MA 02140
US
Trademark representatives
600 Atlantic Avenue
Boston MA 02210-2206
US
goods and services
05
Therapeutic pharmaceuticals for the treatment of disease,
namely, autoimmune diseases and disorders, bone and joint
diseases and disorders, cancer, cardiovascular diseases and
disorders, gastro-intestinal diseases and disorders,
hematologic diseases and disorders, infectious diseases,
kidney diseases and disorders, lung diseases and disorders,
metabolic diseases and disorders, muscle diseases and
disorders, nephrology diseases and disorders,
neurodegenerative diseases and disorders, neurologic
diseases and disorders, ophthalmic disease and disorders,
skin diseases and disorders; pharmaceutical preparations for
the treatment of disease, namely, autoimmune diseases and
disorders, bone and joint diseases and disorders, cancer,
cardiovascular diseases and disorders, gastro-intestinal
diseases and disorders, hematologic diseases and disorders,
infectious diseases, kidney diseases and disorders, lung
diseases and disorders, metabolic diseases and disorders,
muscle diseases and disorders, nephrology diseases and
disorders, neurodegenerative diseases and disorders,
neurologic diseases and disorders, ophthalmic disease and
disorders, skin diseases and disorders; therapeutic
pharmaceuticals for modulating metabolism; pharmaceutical
preparations and agents to modulate metabolism;
pharmaceutical agents that modulate metabolism for
scientific and research use
42
Research and development in the field of computational
biology, biotechnology and pharmaceuticals
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| December 3, 2021 | 2022/8 Gaz | CN | RAW: Rule 18ter(4) all goods and services protected |
| September 16, 2021 | 2021/40 Gaz | US | RAW: Total Ceasing Effect |
| September 8, 2021 | 2021/37 Gaz | CA | Rejection |
| September 2, 2021 | 2021/40 Gaz | IL | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| February 1, 2021 | 2021/5 Gaz | RU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| January 21, 2021 | 2021/38 Gaz | JP | RAW: Second Part Fee Not Paid |
| January 21, 2021 | 2021/3 Gaz | JP | Rejection |
| January 8, 2021 | 2021/2 Gaz | KR | Rejection |
| November 25, 2020 | 2020/49 Gaz | CA | Rejection |
| November 13, 2020 | 2020/48 Gaz | IL | Rejection |
| October 28, 2020 | 2020/44 Gaz | CH | Rejection |
| October 22, 2020 | 2020/43 Gaz | NO | Rejection |
| June 26, 2020 | 2020/27 Gaz | EM | Rejection |
| June 9, 2020 | 2020/24 Gaz | SG | Rejection |
| May 26, 2020 | 2020/22 Gaz | AU | Rejection |
| May 22, 2020 | 2020/22 Gaz | RU | Rejection |
| May 3, 2020 | 2020/19 Gaz | IL | Rejection |
| April 21, 2020 | 2020/17 Gaz | NZ | Rejection |
| April 14, 2020 | 2020/17 Gaz | CN | Rejection |
| February 20, 2020 | 2020/8 Gaz | GB | Rejection |
| October 17, 2019 | 2019/47 Gaz | US | Registration |
ID: 141502261